Table of Contents
ISRN Obstetrics and Gynecology
Volume 2014, Article ID 494695, 4 pages
http://dx.doi.org/10.1155/2014/494695
Research Article

Does Postevacuation β-Human Chorionic Gonadotropin Level Predict the Persistent Gestational Trophoblastic Neoplasia?

1Gynecology Oncology, Tehran University of Medical Sciences (TUMS), Tehran, Iran
2Hormozgan Fertility & Infertility Research Center, Hormozgan University of Medical Sciences, Bandar Abbas 7914964157, Iran
3Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Received 6 February 2014; Accepted 6 March 2014; Published 24 March 2014

Academic Editors: C. Iavazzo, R. Kimmig, K. Nasu, and Y.-S. Song

Copyright © 2014 Azam Sadat Mousavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. D. Kang, H. S. Choi, and S. M. Kim, “Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole,” Gynecologic Oncology, vol. 124, no. 2, pp. 250–253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Monchek and S. Wiedaseck, “Gestational trophoblastic disease: an overview,” Journal of Midwifery & Women's Health, vol. 57, no. 3, pp. 255–259, 2012. View at Google Scholar
  3. K. Seki, H. Matsui, and S. Sekiya, “Advances in the clinical laboratory detection of gestational trophoblastic disease,” Clinica Chimica Acta, vol. 349, no. 1-2, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Alazzam, J. Tidy, B. W. Hancock, and R. Osborne, “First line chemotherapy in low risk gestational trophoblastic neoplasia,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD007102, 2009. View at Google Scholar · View at Scopus
  5. S.-K. Khoo, D. Baartz, M. Sidhu, W.-L. Yip, and L. Tripcony, “Analysis of risk factors for persistent gestational trophoblastic disease,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 49, no. 6, pp. 657–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. E. van Trommel, F. C. G. J. Sweep, C. P. T. Schijf, L. F. A. G. Massuger, and C. M. G. Thomas, “Diagnosis of hydatidiform mole and persistent trophoblastic disease: Diagnosis accuracy of total human chorionic gonadotropin (hCG), free hCG α-and β-subunits, and their ratios,” European Journal of Endocrinology, vol. 153, no. 4, pp. 565–575, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. A. Cole and S. Butler, “Detection of hCG in trophoblastic disease: The USA hCG reference service experience,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 47, no. 6, pp. 433–444, 2002. View at Google Scholar · View at Scopus
  8. B. W. Kim, H. Cho, H. Kim et al., “Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: A case-control study,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 160, no. 1, pp. 100–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. G. Thomas, L. G. W. Kerkmeijer, H. J. W. Ariaens, R. C. B. M. van der Steen, L. F. A. G. Massuger, and F. C. G. J. Sweep, “Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease,” Gynecologic Oncology, vol. 117, no. 1, pp. 47–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Behtash and M. Karimi Zarchi, “Placental site trophoblastic tumor,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Chung and R. Allen, “The use of serial human chorionic gonadotropin levels to establish a viable or a nonviable pregnancy,” Seminars in Reproductive Medicine, vol. 26, no. 5, pp. 383–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Wolfberg, C. Feltmate, D. P. Goldstein, R. S. Berkowitz, and E. Lieberman, “Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy,” Obstetrics and Gynecology, vol. 104, no. 3, pp. 551–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ayhan, Z. S. Tuncer, H. Halilzade, and T. Küçükali, “Predictors of persistent disease in women with complete hydatidiform mole,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 41, no. 8, pp. 591–594, 1996. View at Google Scholar · View at Scopus
  14. U. Kuyumcuoglu, A. I. Guzel, M. Erdemoglu, and Y. Celik, “Risk factors for persistent gestational trophoblastic neoplasia,” Journal of Experimental Therapeutics and Oncology, vol. 9, no. 1, pp. 81–84, 2011. View at Google Scholar · View at Scopus
  15. A. J. Wolfberg, R. S. Berkowitz, D. P. Goldstein, C. Feltmate, and E. Lieberman, “Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy,” Obstetrics and Gynecology, vol. 106, no. 3, pp. 548–552, 2005. View at Google Scholar · View at Scopus
  16. T. Okamoto, K. Matsuo, R. Niu, M. Osawa, and H. Suzuki, “Human chorionic gonadotropin (hCG) β-core fragment is produced by degradation of hCG or free hCGβ in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease,” Journal of Endocrinology, vol. 171, no. 3, pp. 435–443, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Cole, S. A. Butler, S. A. Khanlian et al., “Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia,” Gynecologic Oncology, vol. 102, no. 2, pp. 151–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Jalalian and A. H. Danial, “Writing for academic journals: a general approach,” Electronic Physician, vol. 4, no. 2, pp. 474–476, 2012. View at Google Scholar
  19. M. Jalalian, “Writing an eye-catching and evocative abstract for a research article: a comprehensive and practical approach,” Electronic Physician, vol. 4, no. 3, pp. 520–524, 2012. View at Google Scholar